Alliancebernstein L.P. Mustang Bio, Inc. Transaction History

Alliancebernstein L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.58 - $1.13 $25,114 - $48,928	-43,300 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.73 - $1.81 $7,300 - $18,100	-10,000 Reduced 18.76%	43,300 $44,000
Q2 2021 Jul 30, 2021	BUY	$2.7 - $3.81 $59,670 - $84,201	22,100 Added 70.83%	53,300 $177,000
Q2 2020 Aug 13, 2020	BUY	$2.33 - $4.6 $72,696 - $143,520	31,200 New	31,200 $99,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $23.1M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.